DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform

SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C financing.

Click to view original post